Rosemary Harrison

Insider Reports History

Location
Mississauga, Ontario, Canada
Signature
/s/ Margaret Siegel as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rosemary Harrison:

Company Role Class Num Shares Value Price $ Report Date Ownership
TCR2 THERAPEUTICS INC. Chief Business & Strategy Restricted Stock Unit 0 01 Jun 2023 Direct
TCR2 THERAPEUTICS INC. Chief Business & Strategy Stock Option (Right to Buy) 0 $0.7400 01 Jun 2023 Direct
Trillium Therapeutics Inc. Title: Senior Vice President, Corporate Development and Strategy Common Shares 0 17 Nov 2021 Direct
Trillium Therapeutics Inc. Title: Senior Vice President, Corporate Development and Strategy Stock Option (Right to Buy) 0 17 Nov 2021 Direct

Insider Reports Filed by Rosemary Harrison

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465923067056-harrison-rosemary-2023-06-01 TCR2 THERAPEUTICS INC. 01 Jun 2023 3 $0 4 Chief Business & Strategy 01 Jun 2023, 16:23
/report/000089924322039012-harrison-rosemary-2022-12-15 TCR2 THERAPEUTICS INC. 15 Dec 2022 2 $0 4 Chief Business & Strategy 19 Dec 2022, 16:13
/report/000120919122003013-harrison-rosemary-2022-01-10 TCR2 THERAPEUTICS INC. 10 Jan 2022 1 $0 4 Chief Business & Strategy 12 Jan 2022, 05:57
/report/000120919122003012-harrison-rosemary-2022-01-10 TCR2 THERAPEUTICS INC. 10 Jan 2022 0 $0 3 Chief Business & Strategy 12 Jan 2022, 05:52
/report/000110465921141749-harrison-rosemary-2021-11-17 Trillium Therapeutics Inc. 17 Nov 2021 2 $0 4 Title: Senior Vice President, Corporate Development and Strategy 19 Nov 2021, 12:30